Enantioselective Synthesis of Ozanimod, the Active Pharmaceutical Ingredient of a New Drug for Multiple Sclerosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Enantioselective Synthesis of Ozanimod, the Active Pharmaceutical Ingredient of a New Drug for Multiple Sclerosis

Published:2021-03-24 Issue:12 Volume:2021 Page:1924-1930
ISSN:1434-193X
Container-title:European Journal of Organic Chemistry
language:en
Short-container-title:Eur. J. Org. Chem.

Author:

Cianferotti Claudio¹,Barreca Giuseppe²,Bollabathini Venkatesh¹,Carcone Luca²,Grainger Damian³,Staniland Samantha³,Taddei Maurizio¹^ORCID

Affiliation:

1. Dipartimento di Biotecnologie, Chimica e Farmacia Università degli Studi di Siena Via A. Moro 2 53100 Siena Italy

2. Chemessentia srl Via Bovio 2 28100 Novara Italy

3. Johnson Matthey Catalysis and Chiral Technologies, 28 Cambridge Science Park Milton Road Cambridge CB4 0FP UK

Publisher

Wiley

Subject

Organic Chemistry,Physical and Theoretical Chemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ejoc.202100058

Reference30 articles.

1. Multiple Sclerosis: Mechanisms and Immunotherapy

2. Multiple sclerosis: Pathology, diagnosis and treatments

3. Global, regional, and national burden of multiple sclerosis 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

4. Navigating CYP1A Induction and Arylhydrocarbon Receptor Agonism in Drug Discovery. A Case History with S1P1 Agonists

5. The sphingosine 1-phosphate receptor modulator fingolimod as a therapeutic agent: Recent findings and new perspectives

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Computer-assisted chiral HPLC method development for ozanimod on polysaccharide- based chiral stationary phases: possibilities and limitations;2024-08-23

2. S1PR1 modulators in multiple sclerosis: Efficacy, safety, comparison, and chemical structure insights;European Journal of Medicinal Chemistry;2023-03

3. Overcoming a solid solution system on chiral resolution: combining crystallization and enantioselective dissolution;Chemical Communications;2023

4. Manganese catalysed enantioselective hydrogenation ofin situ-synthesised imines: efficient asymmetric synthesis of amino-indane derivatives;Green Chemistry;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3